iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases

The registry intends to provide real world data on patient management and quality of care for patients with T2DM, hypertension, heat failure and chronic kidney disease in clinical practice in many countries. To bridge this gap an observational voluntary registry is set up to capture real world data on patient characteristics, disease management, healthcare utilization, and outcomes in patients with type 2 diabetes, Hypertension, Heart Failure and Chronic Kidney Disease. Multinational, observational registry utilizing a cloud-based eCRF, for prospective and retrospective data collection, accessible to investigators and Scientific Committee. This registry will be open to all physicians managing T2DM, HTN, HF or CKD across the world

• 1. Incidence of Level 1 Hypoglycemic Events (Blood Glucose <70 mg/dL) [Срок оценки: Average of 3 years]
• 2.Incidence of Level 2 Hypoglycemic Events (Blood Glucose <54 mg/dL) [Срок оценки: Average of 3 years]
• 3.Incidence of Level 3 Hypoglycemic Events (Requiring Third-Party Assistance) [Срок оценки: Average of 3 years]
• 4.Incidence of Diabetic Ketoacidosis (DKA) Episodes [Срок оценки: Average of 3 years]
• 5. Percentage of Participants with Uncontrolled Type 2 Diabetes (HbA1c ≥7%) [Срок оценки: Average of 3 years]
• 6. Percentage of Participants with Uncontrolled Hypertension (BP ≥140/90 mmHg) [Срок оценки: Average of 3 years]
• 7. Incidence of Retinopathy [Срок оценки: Average of 3 years]
• 8. Incidence of Nephropathy [Срок оценки: Average of 3 years]
• 9. Incidence of Neuropathy [Срок оценки: Average of 3 years]
• 10. Incidence of Myocardial Infarction (MI) [Срок оценки: Average of 3 years]
• 11. Incidence of Stroke [Срок оценки: Average of 3 years]
• 12. Incidence of Peripheral Arterial Disease (PAD) [Срок оценки: Average of 3 years]